Literature DB >> 24928039

Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Po-Jen Yen1, Megan E Mefford1, James A Hoxie2, Kenneth C Williams3, Ronald C Desrosiers4, Dana Gabuzda5.   

Abstract

Macrophages play an important role in HIV/SIV pathogenesis by serving as a reservoir for viral persistence in brain and other tissues. Infected macropn>hages have been detected in brain early after infection, but macrophage-tropic viruses are rarely isolated until late-stage infection. Little is known about early variants that establish persistent infection in brain. Here, we characterize a unique macrophage-tropic SIV envelope glycoprotein (Env) variant from two weeks post-infection in blood of an SIVmac251-infected macaque that is closely related to sequences in brain from animals with neurological disease. SIVmac251 clones expressing this Env are highly fusogenic, and replicate efficiently in T cells and macrophages. N173 and N481 were identified as novel determinants of macrophage tropism and neutralization sensitivity. These results imply that macrophage-tropic SIV capable of establishing viral reservoirs in brain can be present in blood during early infection. Furthermore, these SIVmac251 clones will be useful for studies on pathogenesis, eradication, and vaccines.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Envelope glycoprotein (Env); Human immunodeficiency virus (HIV); Macrophage tropism; Simian immunodeficiency virus (SIV)

Mesh:

Substances:

Year:  2014        PMID: 24928039      PMCID: PMC4112485          DOI: 10.1016/j.virol.2014.03.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  89 in total

1.  Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.

Authors:  Manish Sagar; Xueling Wu; Sandra Lee; Julie Overbaugh
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Mechanisms of HIV-1 neurotropism.

Authors:  Rebecca Dunfee; Elaine R Thomas; Paul R Gorry; Jianbin Wang; Petronela Ancuta; Dana Gabuzda
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

Review 3.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

4.  Complex determinants of macrophage tropism in env of simian immunodeficiency virus.

Authors:  K Mori; D J Ringler; T Kodama; R C Desrosiers
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.

Authors:  Rebecca L Dunfee; Elaine R Thomas; Jianbin Wang; Kevin Kunstman; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2007-06-27       Impact factor: 3.616

6.  Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Dafna Bonneh-Barkay; Adam Starkey; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

7.  Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.

Authors:  H Schuitemaker; N A Kootstra; R E de Goede; F de Wolf; F Miedema; M Tersmette
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Authors:  H Schuitemaker; M Koot; N A Kootstra; M W Dercksen; R E de Goede; R P van Steenwijk; J M Lange; J K Schattenkerk; F Miedema; M Tersmette
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

Review 9.  GP120: target for neutralizing HIV-1 antibodies.

Authors:  Ralph Pantophlet; Dennis R Burton
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

10.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

Authors:  Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more
  8 in total

1.  In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.

Authors:  Sanjeev Gumber; Praveen Kumar Amancha; Po-Jen Yen; Francois Villinger; Dana Gabuzda; Siddappa N Byrareddy
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

2.  Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.

Authors:  Guiqing Hu; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.

Authors:  Sarah R DiNapoli; Alexandra M Ortiz; Fan Wu; Kenta Matsuda; Homer L Twigg; Vanessa M Hirsch; Kenneth Knox; Jason M Brenchley
Journal:  JCI Insight       Date:  2017-02-23

4.  Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Authors:  Adrienne E Swanstrom; Beth Haggarty; Andrea P O Jordan; Josephine Romano; George J Leslie; Pyone P Aye; Preston A Marx; Andrew A Lackner; Gregory Q Del Prete; James E Robinson; Michael R Betts; David C Montefiori; Celia C LaBranche; James A Hoxie
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 5.  Non-human primate models of SIV infection and CNS neuropathology.

Authors:  Kenneth Williams; Andrew Lackner; Jaclyn Mallard
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

Review 6.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

7.  Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle.

Authors:  Siddappa N Byrareddy; Dawn Little; Ann E Mayne; Francois Villinger; Aftab A Ansari
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

8.  Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Claudia R Avalos; Sarah L Price; Ellen R Forsyth; Julia N Pin; Erin N Shirk; Brandon T Bullock; Suzanne E Queen; Ming Li; Dane Gellerup; Shelby L O'Connor; M Christine Zink; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.